S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

EWTX Edgewise Therapeutics Inc

27.72

0.69 (2.55%)

After Hours

Last Updated: 08:34:20

Delayed by 15 minutes

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Date of Notice

09/20/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Alan J Russell

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Edgewise Therapeutics (NASDAQ:EWTX)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Edgewise Therapeutics Charts.

Edgewise Therapeutics (NASDAQ:EWTX)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Edgewise Therapeutics Charts.

Edgewise Therapeutics Inc News

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 1 January 2025 (3 days ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Tuesday 31 December 2024 (4 days ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 17 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Edgewise Therapeutics Announces Positive Topline Results from the CANYON Phase 2 Trial of Sevasemten in Individuals with Becker Muscular Dystrophy (Becker)
Monday 16 December 2024 (3 weeks ago) • Business Wire

Edgewise Provides Statement Regarding Company’s Relationship with Dr. Han Phan at Rare Disease Research
Friday 6 December 2024 (4 weeks ago) • Business Wire

Edgewise Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference on December 3, 2024
Tuesday 26 November 2024 (1 month ago) • Business Wire

Form S-8 - Securities to be offered to employees in employee benefit plans
Friday 8 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Friday 8 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 8 November 2024 (2 months ago) • Edgar (US Regulatory)

Edgewise Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
Friday 8 November 2024 (2 months ago) • Business Wire

Edgewise Therapeutics to Present on Sevasemten (EDG-5506) for Becker Muscular Dystrophy (Becker) at the 29th International Annual Congress of the World Muscle Society
Tuesday 1 October 2024 (3 months ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 25 September 2024 (3 months ago) • Edgar (US Regulatory)

More Edgewise Therapeutics Inc News Articles

Westpac Banking

Australia And New Zealan...

AUD vs US Dollar

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions